ANDA 78730, held by ANI Pharmaceuticals. Lansoprazole.
As of Nov 21, 2026, ANDA 78730 (Lansoprazole), held by ANI Pharmaceuticals, was first approved by FDA on Oct 15, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 15, 2010 | Original application | Approved |
| Lansoprazole15MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Discontinued |
| Lansoprazole30MG · tablet, orally disintegrating, delayed release;oral | Lansoprazole | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters